FDA Fast-Tracks Psychedelic Drugs for Depression

Three psychedelic treatments for depression and PTSD could receive FDA approval as soon as this summer, potentially offering hope to millions struggling with mental health conditions.

The accelerated review process cuts approval time from a year down to just weeks.